← Active opportunities
OpenPresolicitation

Continued Operation and Maintenance Support for Agilent Seahorse

Solicitation number75N98026Q01115AGILENTPCANICHD08134

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NATIONAL INSTITUTES OF HEALTH · NATIONAL INSTITUTES OF HEALTH OLAO

View opportunity on SAM.gov ↗
Response deadlineSep 6, 2026, 1:00 PM UTC
Deadline status3 days remaining
PostedAug 28, 2026
Record refreshedSep 2, 2026
Place of performanceBethesda, MD, 20892, United States

Opportunity summary

Source-cited

This presolicitation seeks services for the continued operation and maintenance of the Agilent Seahorse Analyzer at NIH in Bethesda, MD. The required services include on-site preventative maintenance, diagnostics, and repair by certified technicians. [2][1]

Key points

  • Service requires maintenance by manufacturer-certified technicians. [1]
  • Training will be provided on system operation and troubleshooting. [1]

Watch items

  • Response deadline is September 6, 2026. [2]
  • No set-aside is utilized for this requirement. [2]

Sources

  1. SON+Template-Rouault_Seahorse_FY26+(1).docx1. **TYPE OF ORDER (COAC will fill out)** This is a: * Firm Fixed-Price Purchase Order, T&M, Labor Hour, etc. * Severable or Non-Severable 1. **PRODUCT FEATURES/SALIENT CHARACTERISTICS** The Seahorse Analyzer system provides the following essential features to meet NIH research needs: • Real-time, label-free measurement of OCR and ECAR in live cells • Multi-well high-throughput format for parallel analysis of multiple conditions • Compatibility with live adherent and suspension cells from various tissue types • Integrated Wave software for automated assay design, control, and data analysis • Temperature control and minimal sample volume requirements to maintain assay precision The following
  2. Official SAM.gov noticeSet-aside: No Set aside used

Generated from the public notice and source-backed solicitation passages. Confirm important requirements in the cited brief and official documents.

Public-source intelligence

Source-backed opportunity brief

5 citations · 2 sources

1. **TYPE OF ORDER (COAC will fill out)** This is a: * Firm Fixed-Price Purchase Order, T&M, Labor Hour, etc. * Severable or Non-Severable 1. **PRODUCT FEATURES/SALIENT CHARACTERISTICS** The Seahorse Analyzer system provides the following essential features to meet NIH research needs: • Real-time, label-free measurement of OCR and ECAR in live cells • Multi-well high-throughput format for parallel analysis of multiple conditions • Compatibility with live adherent and suspension cells from various tissue types • Integrated Wave software for automated assay design, control, and data analysis • Temperature control and minimal sample volume requirements to maintain assay precision The following product features/characteristics are required for this requirement: • Maintenance and diagnostics performed by manufacturer-certified technicians • Access to proprietary software updates and calibration tools • Use of genuine Agilent replacement parts and consumables * 1. **DELIVERY / INSTALLATION** No physical delivery is required as the system is already installed.

Scope

The requested service includes on-site preventative maintenance, diagnostics, and repair services performed by certified technicians. **4.3 TRAINING** Training will be provided to designated NIH researchers and laboratory staff on optimized system operation, troubleshooting, and software updates during maintenance visits if applicable.

Extracted from the official notice and archived solicitation files. Confirm controlling requirements in the source documents.

Notice information

Read full notice text

The Agilent Seahorse Analyzer housed in Building 35A, Pod D, is a shared core resource utilized by multiple laboratories and Institutes/Centers (ICs) within the NIH intramural research program. This highly specialized metabolic analyzer is critical for real-time measurement of cellular bioenergetics, specifically oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), which are essential for evaluating mitochondrial respiration and glycolysis. The instrument plays a key role in advancing research related to cancer metabolism, neurodegeneration, immunology, and mitochondrial diseases. Consistent operational performance of this system is essential to ensure data quality, experimental reproducibility, and timely progress of high-priority research efforts.

What changed

No field-level changes were detected between related notices.

Notice history

Attachments

Open a filename to view the saved source file. If a saved copy is not available yet, FedRoster will continue to the matching SAM.gov notice.

Back to top ↑